IRIS
FABRIZIO, FEDERICO PIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 90
NA - Nord America 64
AS - Asia 46
Totale 200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58
IE - Irlanda 54
SG - Singapore 37
DE - Germania 15
IT - Italia 14
CN - Cina 5
CA - Canada 4
FI - Finlandia 3
PK - Pakistan 3
FR - Francia 2
CH - Svizzera 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
PA - Panama 1
Totale 200
Salva come PNG Salva come JPEG
Città #
Dublin 54
Boardman 33
Singapore 20
San Giovanni la Punta 9
Beauharnois 4
Catania 3
Helsinki 3
Islamabad 3
Los Angeles 2
Milan 2
Newark 2
Nuremberg 2
Springfield 2
Ashburn 1
Düsseldorf 1
Fort Worth 1
Las Vegas 1
Munich 1
Shanghai 1
Shaoxing 1
Shifangcun 1
Tokyo 1
Zurich 1
Totale 149
Salva come PNG Salva come JPEG
Nome #
Effect of the Mediterranean Diet (MeDi) on the Progression of Retinal Disease: A Narrative Review 16
Epigenetic silencing in clear renal cell carcinoma: KEAP1 promoter hypermethylation 13
Epigenetic Silencing of SPARC in NSCLCs 12
Comparison of Molecular Testing Modalities for Detection of NRG1 Rearrangements in Invasive Mucinous Adenocarcinoma 12
REDOXI-miRNA of Keap1/Nrf2 axis in lung tumors 11
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 10
Identification of EML4-ALK fusion in a sporadic case of cholangiocarcinoma 10
Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy 8
NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows 8
Effects of KEAP1 Silencing on NRF2 and NOTCH Pathways in SCLC Cell Lines 8
Keap1/Nrf2 pathway in kidney cancer: Frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma 8
Erratum: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/ Akt/mTOR survival pathway and inducing apoptosis (Oncotarget. (2021) 12 (1470–1489) DOI: 10.18632/oncotarget.28011) 8
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing 8
B7-H3/CD276 and small-cell lung cancer: What's new? 8
Liquid biopsy and NSCLC 7
Autosomal dominant PTH gene signal sequence mutation in a family with familial isolated hypoparathyroidism 7
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms 7
Methylation density pattern of keap1 gene in lung cancer cell lines detected by quantitative methylation specific PCR and pyrosequencing 6
NRG1-ErbB lost in translation: A new paradigm for lung cancer? 6
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer 6
Frequent NRG1 fusions in caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression 6
Neuroendocrine-related circulating transcripts in small-cell lung cancers: Detection methods and future perspectives 5
Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad 5
Effects of KEAP1 silencing on the regulation of NRF2 activity in neuroendocrine lung tumors 5
Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer 4
Epigenetic versus genetic deregulation of the KEAP1/NRF2 axis in solid tumors: Focus on methylation and noncoding RNAs 4
Automated workflow for somatic and Germline next generation sequencing analysis in routine clinical cancer diagnostics 4
Epigenetic scanning of keap1 cpg sites uncovers new molecular-driven patterns in lung adeno and squamous cell carcinomas 4
ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma 4
NRF2 regulation by noncoding RNAs in cancers: The present knowledge and the way forward 3
Mixed Pulmonary Adenocarcinoma and Atypical Carcinoid: A Report of Two Cases of a Non-codified Entity With Biological Profile 3
Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction 3
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art 3
Next-generation multimodality of nutrigenomic cancer therapy: Sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis 3
Totale 235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025235 72 30 52 30 51 0 0 0 0 0 0 0
Totale 235